Nomura Holdings
CYTR

Nomura Holdings’s CytRx Corp CYTR Stock Holding History

Nomura Holdings’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,400
Closed -$31.9K – 3302
2014
Q1 		$30K Buy
+1,400
New +$49.7K ﹤0.01% 2628
2013
Q4 		– Sell
-6,052
Closed -$118K – 2645
2013
Q3 		$118K Buy
+6,052
New +$89.2K ﹤0.01% 2040

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Nomura Holdings's CYTR Position: Q2 2014 in Review

Nomura Holdings sold out of CytRx Corp (CYTR) in Q2 2014, closing a stake of 1,400 shares — an estimated $31.9K sold.

Nomura Holdings first reported a position in CYTR in Q3 2013 and held it in 2 quarters. The position peaked at $118K in Q3 2013. 74 funds tracked by Wall St. Rank hold CYTR as of Q2 2014.

  • Nomura Holdings reported no remaining CytRx Corp position as of Q2 2014 after selling out during the quarter.
  • Nomura Holdings sold 1,400 CytRx Corp shares in Q2 2014, an estimated $31.9K.
  • Nomura Holdings first reported a position in CytRx Corp in Q3 2013 and held it in 2 quarters.
  • Nomura Holdings's CytRx Corp position peaked at $118K in Q3 2013.
  • 74 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2014.

Based on Nomura Holdings's 13F filing for Q2 2014, filed 13 Aug 2014.